Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02605967
Title Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | FRA

Facility Status City State Zip Country Details
Northwest Georgia Oncology Center NWGA Onc - Carrollton Marietta Georgia 30060 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
NYU Laura and Isaac Perlmutter Cancer Center Laura & Isaac Perlmutter Ctr New York New York 10016 United States Details
Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
Novartis Investigative Site Guangzhou 510060 China Details
Novartis Investigative Site Nice Cedex 2 Alpes Maritimes 06189 France Details
Novartis Investigative Site Villejuif Cedex Villejuif 94800 France Details
Novartis Investigative Site Hong Kong Hong Kong Details
Novartis Investigative Site Kowloon Hong Kong Details
Novartis Investigative Site Tuen Mun Hong Kong Details
Novartis Investigative Site Singapore 169610 Singapore Details
Novartis Investigative Site Tainan Taiwan ROC 70403 Taiwan Details
Novartis Investigative Site Kaohsiung City 83301 Taiwan Details
Novartis Investigative Site Taipei 10002 Taiwan Details
Novartis Investigative Site Taoyuan 33305 Taiwan Details
Novartis Investigative Site Songkhla Hat Yai 90110 Thailand Details
Novartis Investigative Site Bangkok 10330 Thailand Details
Novartis Investigative Site Chiang Mai 50200 Thailand Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field